| NDC Code | 13925-523-01 |
|---|
| Package Description | 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (13925-523-01) |
|---|
| Product NDC | 13925-523 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Azacitidine |
|---|
| Non-Proprietary Name | Azacitidine For |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRAVENOUS; SUBCUTANEOUS |
|---|
| Start Marketing Date | 20170517 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA207518 |
|---|
| Manufacturer | Seton Pharmaceuticals |
|---|
| Substance Name | AZACITIDINE |
|---|
| Strength | 100 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
|---|